Alethia Young

Alethia Young

Director/Board Member at PACIRA BIOSCIENCES, INC.

Net worth: 2 M $ as of 2026-05-30

47 year
Finance
Health Technology
Commercial Services

Profile

Alethia Rene Young is currently an Independent Director at Pacira Biosciences, Inc. since 2023.
Former roles include Director at Build NYC Resource Corp.
from 2021 to 2023, Independent Director at PTC Therapeutics, Inc. from 2022 to 2026, Research Analyst at Credit Suisse Securities (USA) LLC from 2015 to 2018, Healthcare Research Associate at JPMorgan Investment Management, Inc. in 2008, Research Analyst at Deutsche Bank Securities, Inc. from 2011 to 2015, Senior Biotech Analyst & Research Head at Cantor Fitzgerald & Co. from 2018 to 2022, President at Marwood Group LLC from 2008 to 2009, Chief Financial & Accounting Officer at Graphite Bio, Inc. from 2022 to 2023, and Chief Financial Officer at Bicycle Therapeutics Plc from 2023 to 2026.
Education includes an undergraduate degree from Duke University conferred in 2000.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-09 21,067 ( 0.03% ) 2 M $ 2026-05-30
2026-06-09 17,798 ( 0.05% ) 413 270 $ 2026-05-30
2026-01-04 87,081 ( 0.23% ) 408 410 $ 2026-05-30

Alethia Young active positions

CompaniesPositionStart
PACIRA BIOSCIENCES, INC. Director/Board Member 2023-10-09

Former positions of Alethia Young

CompaniesPositionEnd
PTC THERAPEUTICS, INC. Director/Board Member 2026-06-07
BICYCLE THERAPEUTICS PLC Director of Finance/CFO 2026-01-28
LENZ THERAPEUTICS, INC. Director of Finance/CFO 2023-06-29
Director/Board Member 2022-12-31
Director of Research - Equity 2022-03-31
See the detail of Alethia Young's experience

Training of Alethia Young

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Finance

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!